EP3003273A1 — A method for stabilizing tigecycline
Assigned to Xellia Pharmaceuticals ApS · Expires 2016-04-13 · 10y expired
What this patent protects
The present invention relates to a method for stabilizing Tigecycline using nitric acid or sulphuric acid. The present invention furthermore relates to Tigecycline compositions comprising nitric acid or sulphuric acid as the only pH adjusting agent.
USPTO Abstract
The present invention relates to a method for stabilizing Tigecycline using nitric acid or sulphuric acid. The present invention furthermore relates to Tigecycline compositions comprising nitric acid or sulphuric acid as the only pH adjusting agent.
Drugs covered by this patent
- Tygacil (TIGECYCLINE) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.